文献速递甲状腺核医学肿瘤 PET/CT

一站式[18F]氟胆碱PET/CT定位原发性甲状旁腺功能亢进症患者甲状旁腺腺瘤的成本效益分析

Cost-effectiveness of one-stop-shop [18F]Fluorocholine PET/CT to localise parathyroid adenomas in patients suffering from primary hyperparathyroidism.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2024-06-05

该研究用队列级状态转换模型比较术前[18F]氟胆碱PET/CT一站式成像策略与现行最佳实践(仅在[99mTc]Tc-甲氧基异丁基异腈SPECT/CT阴性或不确定时推荐[18F]氟胆碱PET/CT)的成本效益,模拟5万队列。两种策略的长期健康效应与成本相似,无增量净货币效益,一站式策略未降低费用;阈值分析显示[18F]氟胆碱PET/CT定价885欧元时才具成本效益。

要点

  • 两种术前成像策略的长期健康效应与成本相似,一站式策略未降低费用。
  • 在术中甲状旁腺激素监测和传统治疗两种设定下结果一致。
  • [18F]氟胆碱PET/CT定价885欧元是相对现行最佳实践具成本效益的阈值。

核心结论

  • 两种术前成像策略可互换使用,是否实施一站式成像策略应结合当地资源和患者偏好等日常临床实际由决策者判断。

研究设计与样本

  • 队列级状态转换模型,周期长度12个月,采用终身时间范围,模拟5万队列进行概率分析以评估联合参数不确定性。

主要发现

  • 两种成像策略的模拟长期健康效应与成本相似,无增量净货币效益,一站式策略未降低费用,且在术中甲状旁腺激素监测和传统治疗两种设定下结果一致。
  • 阈值分析显示[18F]氟胆碱PET/CT定价885欧元时才相对现行最佳实践具成本效益。

关键数值与推荐

  • 现行最佳实践为仅在[99mTc]Tc-甲氧基异丁基异腈SPECT/CT阴性或不确定时推荐[18F]氟胆碱PET/CT。
  • 一站式策略为术前直接采用[18F]氟胆碱PET/CT成像。
  • [18F]氟胆碱PET/CT定价885欧元为成本效益阈值。

临床怎么用

  • 原文结论认为两种术前成像策略可互换使用,决策应结合当地可用资源和患者偏好。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We conducted a cost-effectiveness analysis in which we compared a preoperative [18F]Fluorocholine PET/CT-based one-stop-shop imaging strategy with current best practice in which [18F]Fluorocholine PET/CT is only recommended after negative or inconclusive [99mTc]Tc-methoxy isobutyl isonitrile SPECT/CT for patients suffering from primary hyperparathyroidism. We investigated whether the one-stop-shop strategy performs as well as current best practice but at lower costs. METHODS: We developed a cohort-level state transition model to evaluate both imaging strategies respecting an intraoperative parathyroid hormone monitored treatment setting as well as a traditional treatment setting. The model reflects patients' hospital journeys after biochemically diagnosed primary hyperparathyroidism. A cycle length of twelve months and a lifetime horizon were used. We conducted probabilistic analyses simulating 50,000 cohorts to assess joint parameter uncertainty. The incremental net monetary benefit and cost for each quality-adjusted life year were estimated. Furthermore, threshold analyses regarding the tariff of [18F]Fluorocholine PET/CT and the sensitivity of [99mTc]Tc-methoxy isobutyl isonitrile SPECT/CT were performed. RESULTS: The simulated long-term health effects and costs were similar for both imaging strategies. Accordingly, there was no incremental net monetary benefit and the one-stop-shop strategy did not result in lower costs. These results applied to both treatment settings. The threshold analysis indicated that a tariff of €885 for [18F]Fluorocholine PET/CT was required to be cost-effective compared to current best practice. CONCLUSION: Both preoperative imaging strategies can be used interchangeably. Daily clinical practice grounds such as available local resources and patient preferences should inform policy-making on whether a hospital should implement the one-stop-shop imaging strategy.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. van Mossel S, Saing S, Appelman-Dijkstra N, et al. Cost-effectiveness of one-stop-shop [18F]Fluorocholine PET/CT to localise parathyroid adenomas in patients suffering from primary hyperparathyroidism. Eur J Nucl Med Mol Imaging. 2024. PMID: 38837058. doi:10.1007/s00259-024-06771-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。